HomeInsightsStock Comparison

Alembic Pharmaceuticals Ltd vs Mankind Pharma Ltd Stock Comparison

Alembic Pharmaceuticals Ltd vs Mankind Pharma Ltd Stock Comparison

Last Updated on: Dec 18, 2025

Key Highlights

  • The Latest Trading Price of Alembic Pharmaceuticals Ltd is ₹ 848.9 as of 18 Dec 15:30.
  • The P/E Ratio of Alembic Pharmaceuticals Ltd changed from 12.1 on March 2020 to 31.3 on March 2025 . This represents a CAGR of 17.16% over 6 yearsThe P/E Ratio of Mankind Pharma Ltd changed from 48.1 on March 2024 to 50.2 on March 2025 . This represents a CAGR of 2.16% over 2 years.
  • The Market Cap of Alembic Pharmaceuticals Ltd changed from ₹ 10059 crore on March 2020 to ₹ 18265 crore on March 2025 . This represents a CAGR of 10.45% over 6 yearsThe Market Cap of Mankind Pharma Ltd changed from ₹ 92029 crore on March 2024 to ₹ 99973 crore on March 2025 . This represents a CAGR of 4.23% over 2 years.
  • The revenue of Alembic Pharmaceuticals Ltd for the Sep '25 is ₹ 1918 crore as compare to the Jun '25 revenue of ₹ 1717 crore. This represent the growth of 11.72% The revenue of Mankind Pharma Ltd for the Sep '25 is ₹ 3791 crore as compare to the Jun '25 revenue of ₹ 3653 crore. This represent the growth of 3.78%.
  • The ebitda of Alembic Pharmaceuticals Ltd for the Sep '25 is ₹ 324.02 crore as compare to the Jun '25 ebitda of ₹ 287.4 crore. This represent the growth of 12.74% The ebitda of Mankind Pharma Ltd for the Sep '25 is ₹ 1015 crore as compare to the Jun '25 ebitda of ₹ 929.82 crore. This represent the growth of 9.22%.
  • The net profit of Alembic Pharmaceuticals Ltd changed from ₹ 120.6 crore to ₹ 183.71 crore over 10 quarters. This represents a CAGR of 18.34% The net profit of Mankind Pharma Ltd changed from ₹ 494.19 crore to ₹ 520.18 crore over 10 quarters. This represents a CAGR of 2.07% .
  • The Dividend Payout of Alembic Pharmaceuticals Ltd changed from 19.45 % on March 2020 to 42.97 % on March 2025 . This represents a CAGR of 14.12% over 6 yearsThe Dividend Payout of Mankind Pharma Ltd changed from 31.56 % on March 2020 to 0 % on March 2025 . This represents a CAGR of -100.00% over 6 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Alembic Pharmaceuticals Ltd

  • Alembic Pharmaceuticals Limited manufactures and markets generic pharmaceutical products all over the world.
  • The company's state of the art research and manufacturing facilities are approved by regulatory authorities of many developed countries including the US FDA. The company is one of the leaders in branded generics in India. Alembic Pharmaceuticals Limited was incorporated on June 16, 2010 as a wholly owned subsidiary of Alembic Limited.
  • The company is engaged in pharmaceuticals business.
  • As per the Scheme of Arrangement, the 'Pharmaceutical Undertaking' of Alembic Limited got demerged and transferred to the Company with effect from April 1, 2010. In April 2011, the company ceased to be a subsidiary of Alembic Ltd consequent to the allotment of 13,35,15,914 equity shares of Rs 2 each to the shareholders of Alembic Ltd as per the scheme of arrangement.

About Mankind Pharma Ltd

  • Mankind Pharma Limited was incorporated on July 3, 1991, as a Private Limited Company with the name 'Mankind Pharma Private Limited', by the Registrar of Companies, Delhi and Haryana, at New Delhi.
  • Pursuant to conversion of Company to a Public Limited dated July 14, 2005, name of the Company was changed to 'Mankind Pharma Limited' and the RoC issued a fresh Certificate of Incorporation on April 13, 2006. The Company is engaged in developing, manufacturing and marketing a diverse range of pharmaceutical formulations and chronic therapeutic areas across, as well as several consumer healthcare products.
  • It is present in several acute and chronic therapeutic areas in India, including anti-infectives, cardiovascular, gastrointestinal, anti-diabetic, neuro/CNS, vitamins /minerals / nutrients and respiratory.

Alembic Pharmaceuticals Ltd News Hub

News

Alembic Pharma receives USFDA approval for Travoprost ophthalmic solution

The approved ANDA is therapeutically equivalent to the reference listed drug (RLD), Travat...

Read more

18 Dec 2025 12:41

News

Alembic receives USFDA approval for Travoprost Ophthalmic Solution

Alembic Pharmaceuticals (Alembic) today announced that it has received final approval from...

Read more

18 Dec 2025 16:44

News

Alembic receives USFDA approval for Loteprednol Etabonate and Tobramycin Ophthalmic Suspension 0.5%/0.3%

Alembic Pharmaceuticals (Alembic) today announced that it has received final approval from...

Read more

11 Dec 2025 15:09

News

Alembic Pharmaceuticals announces change in senior management

Alembic Pharmaceuticals announced that Prashant Khandelwal, Head-International Business Fo...

Read more

01 Dec 2025 19:10

News

Alembic Pharma gains after generic gets USFDA nod

The approval covers strengths of 30 mg, 60 mg, 90 mg and 120 mg. The product is the generi...

Read more

17 Nov 2025 11:54

News

Alembic Pharma gets US FDA approval for angina treatment drug Diltiazem

The approved ANDA is therapeutically equivalent to the reference listed drug (RLD), Cardiz...

Read more

15 Nov 2025 09:45

Mankind Pharma Ltd News Hub

News

Mankind Pharma allots 46,582 equity shares under ESOP

Mankind Pharma has allotted 46,582 equity shares under ESOP on 26 November 2025. With this...

Read more

26 Nov 2025 19:19

News

Mankind Pharma Ltd eases for fifth straight session

Mankind Pharma Ltd dropped for a fifth straight session today. The stock is quoting at Rs ...

Read more

11 Nov 2025 13:35

News

Mankind Pharma receives affirmation in credit ratings from CRISIL

Mankind Pharma has received reaffirmation in credit ratings from CRISIL at CRISIL AA+/ Sta...

Read more

29 Oct 2025 18:55

News

Mankind Pharma schedules board meeting

Mankind Pharma will hold a meeting of the Board of Directors of the Company on 6 November ...

Read more

28 Oct 2025 10:47

News

Mankind Pharma Ltd eases for fifth straight session

Mankind Pharma Ltd fell for a fifth straight session today. The stock is quoting at Rs 249...

Read more

26 Sep 2025 13:35

News

Mankind Pharma allots 29,742 equity shares under ESOP

Mankind Pharma has allotted 29,742 equity shares of face value of Re. 1/- each of the Comp...

Read more

26 Aug 2025 19:59

SWOT Analysis Of Mankind Pharma Ltd

Strength

1

S

Weakness

2

W

Opportunity

0

O

Threats

0

T

SWOT Analysis Of Alembic Pharmaceuticals Ltd

Strength

1

S

Weakness

2

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Mankind Pharma Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Alembic Pharmaceuticals Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Alembic Pharmaceuticals Ltd and Mankind Pharma Ltd

Which company has a larger market capitalization, Alembic Pharmaceuticals Ltd or Mankind Pharma Ltd?

Market cap of Alembic Pharmaceuticals Ltd is 16,686 Cr while Market cap of Mankind Pharma Ltd is 88,468 Cr

What are the key factors driving the stock performance of Alembic Pharmaceuticals Ltd and Mankind Pharma Ltd?

The stock performance of Alembic Pharmaceuticals Ltd and Mankind Pharma Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Alembic Pharmaceuticals Ltd and Mankind Pharma Ltd?

As of December 18, 2025, the Alembic Pharmaceuticals Ltd stock price is INR ₹848.9. On the other hand, Mankind Pharma Ltd stock price is INR ₹2143.1.

How do dividend payouts of Alembic Pharmaceuticals Ltd and Mankind Pharma Ltd compare?

To compare the dividend payouts of Alembic Pharmaceuticals Ltd and Mankind Pharma Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions